Your SlideShare is downloading. ×
0
TexRAD Prostate Cancer
TexRAD Prostate Cancer
TexRAD Prostate Cancer
TexRAD Prostate Cancer
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

TexRAD Prostate Cancer

428

Published on

TexRAD is a software application that analyses the textures in existing radiological scans to assist the clinician in assessing the prognosis of patients with cancer.

TexRAD is a software application that analyses the textures in existing radiological scans to assist the clinician in assessing the prognosis of patients with cancer.

Published in: Health & Medicine, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
428
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Prostate Demo 1 Prostate Demo Case Study | Demo | Evidence Screenshot of the Prostate TexRAD highlighting the conventional CT image of the prostate (top-left), followed by the derived texture maps superimposed on the conventional CT image – fine (red), medium (green) and coarse (blue) texture 5 6 6 7 8 1 2 3 4
  • 2. Prostate Evidence 1 Prostate Early Evidence Clinical Evidence – Submitted an abstract UKRC 2010 [1] Case Study | Demo | Evidence A medium texture (mean grey-level intensity) below 2.4 predicted the presence of tumour with an area under the ROC curve of 0.909, p = 0.0001, sensitivity = 84% and specificity = 84% Texture was significantly different between tumour & normal prostate tissue 5 6 6 7 8 1 2 3 4
  • 3. Prostate Evidence 2 Prostate Early Evidence Clinical Evidence – Submitted an abstract UKRC 2010 [1] Case Study | Demo | Evidence Medium mean grey-level intensity correlates inversely with Prognostic risk factors (determined on the basis of gleason score, PSA level and clinical T stage) Texture correlates with prognostic risk factor (adverse tumour biology and/or patient outcome) 5 6 6 7 8 1 2 3 4
  • 4. References - Prostate <ul><li>PROSTATE </li></ul><ul><li>1. Ganeshan B, Rajpopat M, Young RCD, Chatwin CR, Tremlett J, Robinson A, Miles KA. Preliminary evidence of altered texture on CT. Submitted as a paper to UK Radiological Congress 2010, Birmingham, UK. </li></ul>References - Prostate Cancer Colorectal | Lung | Breast | Prostate | Renal | Lung | Brain | DTA

×